Security key
037326105
AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)
CUSIP: 037326105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 13,513,224
- Total 13F value
- $14,458,906
- Share change
- -5,904,158
- SEC-reported price per share
- $1.07
- Number of holders
- 31
- Value change
- -$16,315,888
- Number of buys
- 15
- Number of sells
- 29
- Shares outstanding
- 38,076,587
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
31
Top holders
10
ANTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
AN2 Therapeutics, Inc. SEC filings
AN2 Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 037326105
Recent filing periods:
Ownership snapshot
Top reported holders of ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Adjuvant Global Health Te...
Disclosed value leader
Adjuvant Global Health Te...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $45,367,317
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Adjuvant Global Health Technology Fund, L.P. has the largest disclosed position value at $45.37M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Adjuvant Global Health Technology Fund, L.P.'s linked filing trail.
Disclosed position value
Top 5
Adjuvant Global Health Technology...
$45.37M
RA CAPITAL MANAGEMENT, L.P.
$11.94M
Octagon Capital Advisors LP
$6.92M
Frazier Life Sciences Management,...
$4.49M
TCG Crossover Management, LLC
$3.34M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Adjuvant Global Health Technology Fund, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$45,367,317
2,373,500 shares
|
— | 16 Jan 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$11,935,284
5,551,295 shares
|
— | 30 Jun 2024 |
| Octagon Capital Advisors LP |
13F
Company
|
—
denominator unverified
|
$6,923,565
3,220,263 shares
|
— | 30 Jun 2024 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$4,491,111
2,088,889 shares
|
— | 30 Jun 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
—
denominator unverified
|
$3,343,504
1,555,118 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$3,340,732
1,553,829 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
13,513,224
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2026 Across Filers
Q2 2026 holders
66
Q3 2024 holders
31
Holder diff
-35
| Investor | Q2 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend